title: Myc and AP-1 expression in T cells and T-cell activation in patients after hematopoietic stem cell transplantation.
abstract: Regeneration of the immune system after hematopoietic stem cell transplantation (HSCT) is a slow process. We attempted to identify problems in the recovery of the immune system by examining expressions of early event cell cycle proteins Myc, Jun, and Fos, as well as DNA binding of Myc, activating protein 1 (AP-1), and CD4 cell activation values, in phytohemagglutinin-activated T lymphocytes taken from patients after HSCT. HSCT patients showed lower protein expression levels of Myc and Jun, as well as Myc and AP-1 DNA-binding levels, as compared to healthy controls. C-Jun was lower in long-term survivors of HSCT than short-term survivors. Adenosine triphosphate (ATP) values in CD4 cells were also lower in HSCT patients than healthy controls, but showed a time-dependent increase post-transplant. Non-surviving patients showed lower levels of both Fos protein and ATP as compared to surviving patients and a negative correlation between Fos values and lymphocyte percentage that was not present in surviving patients. There was a strong positive correlation between Fos values and lymphocyte percentage and between AP-1 values and white blood count, in patients without graft-versus-host disease (GVHD), that did not exist in patients who suffered from GVHD. Patients 2 years post-HSCT showed a positive correlation between AP-1 and Myc DNA-binding protein values, similar to those values found in healthy controls. Our study identified significant factors that account for the delay in immune reconstitution after transplant; this knowledge may improve the management of post-HSCT patients.
authors.affiliation: Faculty of Medicine, The Institute of Medical Research, Hebrew University of Jerusalem, Jerusalem, Israel.
authors.forename: Shivtia
authors.initials: S
authors.lastname: Trop-Steinberg
authors.forename: Yehudith
authors.initials: Y
authors.lastname: Azar
authors.forename: Rachel
authors.initials: R
authors.lastname: Bringer
authors.forename: Reuven
authors.initials: R
authors.lastname: Or
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D002648:Child; D005260:Female; D020869:Gene Expression Profiling; D005786:Gene Expression Regulation; D018380:Hematopoietic Stem Cell Transplantation; D006801:Humans; D008213:Lymphocyte Activation; D008297:Male; D008875:Middle Aged; D016271:Proto-Oncogene Proteins c-myc / Q000096:biosynthesis*; D013601:T-Lymphocytes / Q000502:physiology*; D013997:Time Factors; D018808:Transcription Factor AP-1 / Q000096:biosynthesis*; D055815:Young Adult
chemical_list: C489427:MYC protein, human; D016271:Proto-Oncogene Proteins c-myc; D018808:Transcription Factor AP-1
references.citation: Mol Immunol. 2010 Aug;47(14):2314-22
references.pmid: 20557936
references.citation: J Biol Chem. 2010 Feb 19;285(8):5488-96
references.pmid: 20028981
references.citation: Crit Rev Oncol Hematol. 2007 Oct;64(1):49-63
references.pmid: 17303434
references.citation: J Immunol. 1987 May 15;138(10):3495-504
references.pmid: 3106484
references.citation: Eur J Immunol. 2012 Jul;42(7):1850-62
references.pmid: 22585681
references.citation: Ann Surg. 1994 Sep;220(3):342-51; discussion 351-2
references.pmid: 8092900
references.citation: Blood. 2001 Dec 15;98(13):3505-12
references.pmid: 11739150
references.citation: Bone Marrow Transplant. 2010 Mar;45(3):527-33
references.pmid: 19718067
references.citation: Leuk Res. 1985;9(7):833-42
references.pmid: 3860696
references.citation: J Leukoc Biol. 1998 Feb;63(2):139-52
references.pmid: 9468273
references.citation: Transpl Immunol. 2013 Dec;29(1-4):146-54
references.pmid: 23578467
references.citation: Transplantation. 2006 Sep 15;82(5):663-8
references.pmid: 16969290
references.citation: Bone Marrow Transplant. 1999 Mar;23(5):451-7
references.pmid: 10100558
references.citation: Vox Sang. 1998;75(2):134-8
references.pmid: 9784667
references.citation: Transplantation. 2000 Apr 15;69(7):1341-7
references.pmid: 10798751
references.citation: Cell Immunol. 1999 Oct 10;197(1):19-29
references.pmid: 10555992
references.citation: J Immunol. 1993 Apr 15;150(8 Pt 1):3148-60
references.pmid: 8468462
references.citation: Transplantation. 2001 Oct 27;72(8):1416-22
references.pmid: 11685114
references.citation: Mol Cell Biol. 1992 Aug;12(8):3548-55
references.pmid: 1352852
references.citation: N Engl J Med. 1998 Jun 18;338(25):1813-21
references.pmid: 9632449
references.citation: Mol Immunol. 2013 Nov;56(1-2):48-56
references.pmid: 23665382
references.citation: Cancer Lett. 2013 Jan 28;328(2):198-206
references.pmid: 23022474
references.citation: Blood. 2002 Sep 15;100(6):2235-42
references.pmid: 12200390
references.citation: J Surg Res. 2012 Jul;176(1):e41-6
references.pmid: 22342379
references.citation: Cell Immunol. 1993 Nov;152(1):96-109
references.pmid: 8242776
references.citation: Blood. 2003 Dec 15;102(13):4600-7
references.pmid: 12933579
references.citation: EMBO J. 2002 Dec 2;21(23):6321-9
references.pmid: 12456639
references.citation: Int Immunol. 2011 Nov;23(11):661-8
references.pmid: 21948191
references.citation: J Immunol. 1990 May 1;144(9):3569-73
references.pmid: 2184192
references.citation: Cell Immunol. 1997 Jan 10;175(1):41-50
references.pmid: 9015187
references.citation: Clin Transplant. 2003 Apr;17(2):77-88
references.pmid: 12709071
references.citation: Immunol Lett. 1989 Jul;22(1):47-50
references.pmid: 2777334
references.citation: Dan Med Bull. 2007 May;54(2):112-39
references.pmid: 17521527
references.citation: J Immunol. 1987 Oct 1;139(7):2143-8
references.pmid: 2821108
references.citation: Blood. 2006 Oct 15;108(8):2669-77
references.pmid: 16788099
references.citation: Clin Immunol Immunopathol. 1993 Dec;69(3):314-7
references.pmid: 8242902
references.citation: Nat Rev Cancer. 2003 Nov;3(11):859-68
references.pmid: 14668816
references.citation: Eur J Immunol. 1986 Oct;16(10):1217-21
references.pmid: 3095123
references.citation: Leukemia. 2007 Aug;21(8):1628-37
references.pmid: 17525730
references.citation: Clin Diagn Lab Immunol. 2000 Mar;7(2):307-11
references.pmid: 10702511
references.citation: EMBO J. 1988 Sep;7(9):2787-94
references.pmid: 3053165
references.citation: Cell Signal. 2005 Sep;17(9):1111-24
references.pmid: 15993752
references.citation: Immunol Rev. 1997 Jun;157:73-8
references.pmid: 9255623
references.citation: Mech Ageing Dev. 1992 Sep;65(2-3):149-56
references.pmid: 1434944
references.citation: J Immunol. 1986 Aug 1;137(3):764-9
references.pmid: 3088109
references.citation: Clin Transplant. 2008 Jan-Feb;22(1):55-60
references.pmid: 18217906
references.citation: Cell. 1990 Oct 19;63(2):341-51
references.pmid: 2119889
references.citation: Blood. 1998 Sep 1;92(5):1471-90
references.pmid: 9716573
references.citation: Cell. 2002 Jun 14;109(6):719-31
references.pmid: 12086671
references.citation: Immunity. 2011 Dec 23;35(6):871-82
references.pmid: 22195744
references.citation: Mol Cell. 2002 May;9(5):1017-29
references.pmid: 12049738
references.citation: Biochem Int. 1990 Nov;22(3):397-403
references.pmid: 2076099
references.citation: Int Immunol. 1999 Aug;11(8):1203-16
references.pmid: 10421778